http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0311540-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86de07505ef9a9cb798c158f2cb9c653
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 1988-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84d20960c35a6ea4ac887ee91080f915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bddfea9d078ea7bee55d0cf0304f61a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82f1ec49572740dabdb110167b2c7e55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2de95a6870d834d42b63198f89b14da9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa0f8dee46719beff7335b99ffe8034
publicationDate 1989-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0311540-A1
titleOfInvention Galenical forms of corticoids for per- and sublingual administration, and their preparation process
abstract In these new dosage forms, the corticosteroid is contained, in strictly controlled and reproducible quantities, in solid supports intended for a progressive release of the active principle by sublingual peret.n n n Luckily, the corticosteroid is methyl prednisolone.n n n Their preparation process includes the following main steps: - dissolving the corticosteroid in a solvent, - preparation of dilutions at different concentrations, - splitting of each of these dilutions into under-dilutions, - impregnation by multi-impregnation or fractional impregnation of a solid pharmaceutically acceptable support with each of the sub-dilutions, each of said impregnation steps being followed by drying in forced air and dried at a temperature less than or equal to 35 ° C. .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925139-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2766367-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005235369-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9940898-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9904759-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005102287-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9940898-A2
priorityDate 1987-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0205282-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-156609-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4259314-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6400916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946

Total number of triples: 44.